The traditional distinction between NSTE-ACS (Non-STEMI) and STE-ACS (STEMI) is slightly simplified. In reality the course in myocardial infarction is modified by a range of factors. The most important of these factors, and their implications, are as follows:
- The size of the thrombus (i.e the degree of luminal obstruction): The greater the obstruction the more extensive the ischemia/infarction.
- The localization of the thrombus: a proximally located thrombus will cut off blood flow to more branches, and thus more myocardium, than a distally located thrombus.
- The duration of the ischemia: the longer the duration of the ischemia, the more extensive the infarction.
These three are perhaps the most important factors determining the infarct size. However, there are additional factors which certainly deserves mention.
Coronary artery collateral circulation
Coronary collateral circulation may be extremely important. Collateral circulation develop in ischemic myocardium because longstanding ischemia causes the myocardium to secrete growth factors (particularly VEGF) which stimulates nearby arteries to grow new vessels into the ischemic zone. Newly formed vessels, which may originate from other branches of the same coronary artery or another coronary artery, will alleviate the ischemia, improve myocardial function and increase resistance to episodes of more severe ischemia.
Collateral circulation may be very effective in reducing ischemia. Indeed, it may be so efficient that a total occlusion in the main artery may not elad to infarction because of the collaterals. Occasionally, patients with total and proximal occlusions present without ST-segment elevations (which they should exhibit) due to extensive collateral circulation in the ischemic area. Moreover, intensive collateral circulation may also prevent ischemia from occurring during exercise stress testing, which leads to false negative stress test. Studies have shown that if the myocardium obtains 30% of its resting perfusion from collaterals, it may survive for 60 minutes in case of a total occlusion or >5 hours in the case of partial occlusion.
Coronary artery anatomy
There is individual variation in the coronary artery anatomy. These details will be discussed in later chapters. As for now, it is sufficient to note that the more myocardium supplied by an artery, the greater the ischemic area in case of an occlusion.
Ischemic preconditioning: preparing for ischemia
The concept of ischemic preconditioning was developed two decades ago. In experiments conducted in the canine heart, it was shown that applying a 5-minute occlusion-reflow cycle repeatedly to the circumflex artery before a 60-minute occlusion of the left anterior descending coronary artery (LAD) would reduce the infarct size by 60%, as compared with directly occluding the LAD. Hence it was believed that the muscle could be preconditioned (acclimatized) to ischemia from a distance. It was, and still is, suggested that ischemic myocardium secretes protective substances that affect and precondition the metabolism other myocardial cells.
Researchers have often pushed the notion that repeated cycles of transient ischemia is what induces the protective effect. Several studies (including randomized clinical trials) have shown a benefit of ischemic preconditioning, while other studies have failed to establish such a relation. The most cited study to date is Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, in patients with acute myocardial infarction by Botker et al, The Lancet 2010, which reported that that remote ischaemic conditioning increases myocardial salvage. The reason why this is a highly interesting research question is because identification of a protective factor may result in a very useful medication for patients with ischemia. Nevertheless, the mechanisms underlying ischemic preconditioning, and whether it actually works, remain elusive. A recent study, published in the New England Journal of Medicine, failed to show any effect of remote ischemic conditioning (Hausenloy et al. The New England Journal of Medicine, 2016)
Beta-blockers have a negative chronotropic and inotropic effect which means that they slow the heart rate and diminish contractility. This reduces myocardial metabolism and thus ischemia. Studies performed in the 1980s and 1990s showed that administration of beta-blockers could limit infarct size (Yusuf et al, Swedberg et al, Herlitz et al).
Aspirin is extremely effective in reducing infarct size. Early studies conducted decades ago showed that aspirin may reduce the risk of death by 50% in STE-ACS (STEMI) and 20–30% in NSTE-ACS (Non-STEMI).
Statins do not affect the risk of infarction/mortality in the short-term, but certainly in the long term.
Interestingly, studies show that the more cardioprotective medications in use, the lower the risk of developing STE-ACS in the case of acute coronary syndromes. Hence, these evidence based medications may reduce the risk of developing total and proximal occlusions.
Tachycardia, anemia and hypotension aggravate the situation in acute coronary syndromes and lead to larger infarctions if left untreated.